• Fri news: New Novo obesity prospect linked to psychiatric side effects. Summit beats Keytruda in NSCLC. DermaSensor skin cancer detection device. Astellas digital health product. Sanofi MS data. See more on our front page

FDA Warns of Potential Cancer Risk With Weight Loss Drug

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 14, 2020 at 10:02: PM
via The US Food and Drug Administration (FDA) on Tuesday alerted the public to the results from a clinical trial that showed a possible increased risk of cancer with Eisai’s weight management drug Belviq (lorcaserin) and the extended release version.

article source
 

<



Similar threads

cafead
FDA warns of potential risk from Hologic&#039;s devices implanted in soft tissue
Replies
0
Views
141
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA warns small biotech Ocugen of potential $10K fines for failing to post trial results
Replies
0
Views
124
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA Warns of Potential Contamination With Some Cardinal Health Surgical Gowns
Replies
0
Views
204
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA warns providers not to buy or implant Synovo’s total hip system
Replies
0
Views
205
Pharma/Biotech Companies - In the News
cafead
cafead
cafead
FDA warns about counterfeit versions of Novo&#039;s diabetes drug Ozempic
Replies
0
Views
358
Pharma/Biotech Companies - In the News
cafead
cafead
Top Bottom
Back
Quote